Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Free Communications

Growth-promoting therapies

Safety and Effectiveness of Increlex Therapy in Children with Laron Syndrome and Enrolled in the European Increlex Growth Forum Database in Europe
aFaculty of Health Sciences, Linköping University, Linköping, Sweden; bHôpital Universitaire Necker Enfants Malades, Université Paris Descartes, Paris, France; cChildren’s Hospital, University of Bonn, Bonn, Germany; dIPSEN Pharma, Boulogne Billancourt, France
hrp0084fc7.1
IGF1 Levels, Complex Formation, and IGF-Bioactivity in GH-Treated Children with Prader-Willi Syndrome
aDutch Growth Research Foundation, Rotterdam, The Netherlands; bSubdivision of Endocrinology, Department of Pediatrics, Erasmus MC, Sophia Children’s Hospital, Rotterdam, The Netherlands; cSection Metabolic Diseases, Laboratory of Endocrinology, Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands; dSection Metabolic Diseases, Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
hrp0084fc7.3
A Novel Reversible Albumin-Binding GH Derivative Possesses a Promising Once-Weekly Treatment Profile in Children with GH Deficiency
aBruce Rappaport Faculty of Medicine, Rambam Medical Center, Haifa, Israel; bUniversity Children’s Hospital, Skopje, Macedonia; cNovo Nordisk A/S, Søborg, Denmark; dUMC-University Children’s Hospital, Ljubljana, Slovenia; eKarolinska Institutet, Stockholm, Sweden; fDivision of Paediatric Endocrinology, UZ Brussel, Laarbeeklaan, Brussels, Belgium
hrp0084fc7.4
12-Month Safety and Efficacy of a Weekly Long-Acting GH (MOD-4023) Compared to Daily Recombinant Human GH Therapy in Pre-Pubertal GH-Deficient Children; Phase 2 Study: Study CP-4-004 Summary
aOpko Biologics Ltd, Nes Ziona, Israel; bKaplan Medical Center, Rehovot, Israel; cDepartment of Pediatrics, OHSU, Portland, Oregon, USA; d2nd Children City Clinic, Department of Endocrinology, Minsk, Belarus; eEndocrinology Department, Ukrainian Children Specialized Clinical Hospital, Kyev, Ukraine; fDepartment of Pediatrics, Bashkir State Medical University, Ufa, Russia; gUMHAT, Sv. Marina’ Multiprofile Specialised Pediatrics Clinic, Varna, Bulgaria; hPediatrics and Endocrinology, St Petersburg State Pediadric Medical Academy, St Petersburg, Russia
hrp0084fc7.5